SCH 42495 is an orally active neutral endopeptidase (NEP) inhibitor with antihypertensive activity; it serves as an oral prodrug of SCH 42354. It significantly reduces pulmonary vascular remodeling and ventricular hypertrophy in hypoxic rats; attenuates cardiovascular remodeling secondary to chronic hypoxia; and produces dose-dependent reductions in blood pressure in DOCA-salt hypertensive rats.